Wetenschappelijke publicaties van Bordet

Wetenschappelijke publicaties van Bordet

Clinical Behavior of Breast Cancer in Young <i>BRCA</i> Carriers and Prediagnostic Awareness of Germline <i>BRCA</i> Status.

Lambertini M, Blondeaux E, Tomasello LM, Agostinetto E, Hamy AS, Kim HJ, Franzoi MA, Bernstein-Molho R, Hilbers F, Pogoda K, Wildiers H, Bajpai J, Ignatiadis M, Moore HCF, Partridge AH, Phillips KA, Toss A, Rousset-Jablonski C, Criscitiello C, Renaud T, Ferrari A, Paluch-Shimon S, Fruscio R, Cui W, Wong SM, Vernieri C, Ruddy KJ, Dieci MV, Matikas A, Rozenblit M, Villarreal-Garza C, De Marchis L, Puglisi F, Rodriguez-Wallberg KA, Duhoux FP, Livraghi L, Bruzzone M, Boni L, Balmaña J

Clinical Behavior of Breast Cancer in Young <i>BRCA</i> Carriers and Prediagnostic Awareness of Germline <i>BRCA</i> Status.

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Metoikidou C, Karnaukhov V, Boeckx B, Timperi E, Bonté PE, Wang L, Espenel M, Albaud B, Loirat D, Wang X, Sotiriou C, Aftimos P, Punie K, Wildiers H, Labroska V, Wang MW, Waterfall JJ, Piccart-Gebhart M, Mora T, Walczak A, Lantz O, Buisseret L, Lambrechts D, Amigorena S, Romano E

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Metoikidou C, Karnaukhov V, Boeckx B, Timperi E, Bonté PE, Wang L, Espenel M, Albaud B, Loirat D, Wang X, Sotiriou C, Aftimos P, Punie K, Wildiers H, Labroska V, Wang MW, Waterfall JJ, Piccart-Gebhart M, Mora T, Walczak A, Lantz O, Buisseret L, Lambrechts D, Amigorena S, Romano E

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Metoikidou C, Karnaukhov V, Boeckx B, Timperi E, Bonté PE, Wang L, Espenel M, Albaud B, Loirat D, Wang X, Sotiriou C, Aftimos P, Punie K, Wildiers H, Labroska V, Wang MW, Waterfall JJ, Piccart-Gebhart M, Mora T, Walczak A, Lantz O, Buisseret L, Lambrechts D, Amigorena S, Romano E

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Metoikidou C, Karnaukhov V, Boeckx B, Timperi E, Bonté PE, Wang L, Espenel M, Albaud B, Loirat D, Wang X, Sotiriou C, Aftimos P, Punie K, Wildiers H, Labroska V, Wang MW, Waterfall JJ, Piccart-Gebhart M, Mora T, Walczak A, Lantz O, Buisseret L, Lambrechts D, Amigorena S, Romano E

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.

Roux A, Hervouet L, Stefano FD, French DP, Giordano L, Ritchie D, Bugat MR, Keatley D, Cholerton R, McWilliams L, Rossi PG, Balleyguier C, Guindy M, Gilbert FJ, Burrion JB, Roman M, Vissac-Sabatier C, Couch D, Delaloge S, Montgolfier S

Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.

Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial.

Caluwé A, Bellal S, Cao K, Peignaux K, Remouchamps V, Baten A, Longton E, Bessieres I, Vu-Bezin J, Kirova Y, Gestel DV, Desmoulins I, Ignatiadis M, Romano E, Buisseret L, Piccart M, Vandekerkhove C, Gulyban A, Poortmans P

Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial.
Erasme hospital

Erasmusziekenhuis

Bekijk alle wetenschappelijke publicaties van Erasmus

Wetenschappelijke publicaties van Erasmus
Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Wetenschappelijke publicaties van het Koningin Fabiola-Kinderziekenhuis
Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Jules Bordet